Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Infectious Diseases |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000200207 |
Resumo: | ABSTRACT Introduction: Some COVID-19 patients have higher mortality and the responsible factors for this unfavorable outcome is still not well understood. Objective: To study the association between ferritin levels at admission, representing an inflammatory state, and hospital mortality in COVID-19 patients. Methods: From May through July 2020, SARS-CoV-2 positive patients with moderate to severe clinical symptoms were evaluated at admission, regarding clinical and laboratory data on renal and hepatic function, hematologic parameters, cytomegalovirus co-infection, and acute phase proteins. Results: A total of 97 patients were included; mean age = 59.9 ± 16.3 years, 58.8% male, 57.7% non-white, in-hospital mortality = 45.4%. Age, ferritin, C-reactive protein, serum albumin and creatinine were significantly associated with mortality. Ferritin showed area under the curve (AUC) of 0.79 (p < 0.001) for the cut-off of 1873.0 ng/mL, sensitivity of 68.4% and specificity of 79.3% in predicting in-hospital mortality. Age ≥60 years had an odds ratio (OR) of 10.5 (95% CI = 1.8–59.5; p = 0.008) and ferritin ≥1873.0 ng/mL had an OR of 6.0 (95% CI = 1.4–26.2; p = 0.016), both independently associated with mortality based on logistic regression analysis. Conclusion: The magnitude of inflammation present at admission of COVID-19 patients, represented by high ferritin levels, is independently predictive of in-hospital mortality. |
id |
BSID-1_0a20fe44cc8d7891a7574fdba721c57d |
---|---|
oai_identifier_str |
oai:scielo:S1413-86702021000200207 |
network_acronym_str |
BSID-1 |
network_name_str |
Brazilian Journal of Infectious Diseases |
repository_id_str |
|
spelling |
Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortalitySARS-CoV-2FerritinMortalityCytokine stormHemophagocytic lymphohistiocytosisABSTRACT Introduction: Some COVID-19 patients have higher mortality and the responsible factors for this unfavorable outcome is still not well understood. Objective: To study the association between ferritin levels at admission, representing an inflammatory state, and hospital mortality in COVID-19 patients. Methods: From May through July 2020, SARS-CoV-2 positive patients with moderate to severe clinical symptoms were evaluated at admission, regarding clinical and laboratory data on renal and hepatic function, hematologic parameters, cytomegalovirus co-infection, and acute phase proteins. Results: A total of 97 patients were included; mean age = 59.9 ± 16.3 years, 58.8% male, 57.7% non-white, in-hospital mortality = 45.4%. Age, ferritin, C-reactive protein, serum albumin and creatinine were significantly associated with mortality. Ferritin showed area under the curve (AUC) of 0.79 (p < 0.001) for the cut-off of 1873.0 ng/mL, sensitivity of 68.4% and specificity of 79.3% in predicting in-hospital mortality. Age ≥60 years had an odds ratio (OR) of 10.5 (95% CI = 1.8–59.5; p = 0.008) and ferritin ≥1873.0 ng/mL had an OR of 6.0 (95% CI = 1.4–26.2; p = 0.016), both independently associated with mortality based on logistic regression analysis. Conclusion: The magnitude of inflammation present at admission of COVID-19 patients, represented by high ferritin levels, is independently predictive of in-hospital mortality.Brazilian Society of Infectious Diseases2021-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000200207Brazilian Journal of Infectious Diseases v.25 n.2 2021reponame:Brazilian Journal of Infectious Diseasesinstname:Brazilian Society of Infectious Diseases (BSID)instacron:BSID10.1016/j.bjid.2021.101569info:eu-repo/semantics/openAccessLino,KatiaGuimarães,Gabriel Macedo CostaAlves,Lilian SantosOliveira,Any CarolineFaustino,RenanFernandes,Cintia SouzaTupinambá,GleiserMedeiros,ThaliaSilva,Andrea Alice daAlmeida,Jorge Reiseng2021-06-16T00:00:00Zoai:scielo:S1413-86702021000200207Revistahttps://www.bjid.org.br/https://old.scielo.br/oai/scielo-oai.phpbjid@bjid.org.br||lgoldani@ufrgs.br1678-43911413-8670opendoar:2021-06-16T00:00Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)false |
dc.title.none.fl_str_mv |
Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality |
title |
Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality |
spellingShingle |
Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality Lino,Katia SARS-CoV-2 Ferritin Mortality Cytokine storm Hemophagocytic lymphohistiocytosis |
title_short |
Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality |
title_full |
Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality |
title_fullStr |
Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality |
title_full_unstemmed |
Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality |
title_sort |
Serum ferritin at admission in hospitalized COVID-19 patients as a predictor of mortality |
author |
Lino,Katia |
author_facet |
Lino,Katia Guimarães,Gabriel Macedo Costa Alves,Lilian Santos Oliveira,Any Caroline Faustino,Renan Fernandes,Cintia Souza Tupinambá,Gleiser Medeiros,Thalia Silva,Andrea Alice da Almeida,Jorge Reis |
author_role |
author |
author2 |
Guimarães,Gabriel Macedo Costa Alves,Lilian Santos Oliveira,Any Caroline Faustino,Renan Fernandes,Cintia Souza Tupinambá,Gleiser Medeiros,Thalia Silva,Andrea Alice da Almeida,Jorge Reis |
author2_role |
author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Lino,Katia Guimarães,Gabriel Macedo Costa Alves,Lilian Santos Oliveira,Any Caroline Faustino,Renan Fernandes,Cintia Souza Tupinambá,Gleiser Medeiros,Thalia Silva,Andrea Alice da Almeida,Jorge Reis |
dc.subject.por.fl_str_mv |
SARS-CoV-2 Ferritin Mortality Cytokine storm Hemophagocytic lymphohistiocytosis |
topic |
SARS-CoV-2 Ferritin Mortality Cytokine storm Hemophagocytic lymphohistiocytosis |
description |
ABSTRACT Introduction: Some COVID-19 patients have higher mortality and the responsible factors for this unfavorable outcome is still not well understood. Objective: To study the association between ferritin levels at admission, representing an inflammatory state, and hospital mortality in COVID-19 patients. Methods: From May through July 2020, SARS-CoV-2 positive patients with moderate to severe clinical symptoms were evaluated at admission, regarding clinical and laboratory data on renal and hepatic function, hematologic parameters, cytomegalovirus co-infection, and acute phase proteins. Results: A total of 97 patients were included; mean age = 59.9 ± 16.3 years, 58.8% male, 57.7% non-white, in-hospital mortality = 45.4%. Age, ferritin, C-reactive protein, serum albumin and creatinine were significantly associated with mortality. Ferritin showed area under the curve (AUC) of 0.79 (p < 0.001) for the cut-off of 1873.0 ng/mL, sensitivity of 68.4% and specificity of 79.3% in predicting in-hospital mortality. Age ≥60 years had an odds ratio (OR) of 10.5 (95% CI = 1.8–59.5; p = 0.008) and ferritin ≥1873.0 ng/mL had an OR of 6.0 (95% CI = 1.4–26.2; p = 0.016), both independently associated with mortality based on logistic regression analysis. Conclusion: The magnitude of inflammation present at admission of COVID-19 patients, represented by high ferritin levels, is independently predictive of in-hospital mortality. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000200207 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702021000200207 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1016/j.bjid.2021.101569 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Brazilian Society of Infectious Diseases |
publisher.none.fl_str_mv |
Brazilian Society of Infectious Diseases |
dc.source.none.fl_str_mv |
Brazilian Journal of Infectious Diseases v.25 n.2 2021 reponame:Brazilian Journal of Infectious Diseases instname:Brazilian Society of Infectious Diseases (BSID) instacron:BSID |
instname_str |
Brazilian Society of Infectious Diseases (BSID) |
instacron_str |
BSID |
institution |
BSID |
reponame_str |
Brazilian Journal of Infectious Diseases |
collection |
Brazilian Journal of Infectious Diseases |
repository.name.fl_str_mv |
Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID) |
repository.mail.fl_str_mv |
bjid@bjid.org.br||lgoldani@ufrgs.br |
_version_ |
1754209245176266752 |